These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25107939

  • 1. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
    Mozo L, López P, Caminal-Montero L, Rodríguez-Carrio J, Suárez A.
    Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
    [Abstract] [Full Text] [Related]

  • 2. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
    Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R.
    Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
    [Abstract] [Full Text] [Related]

  • 3. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M, Francis S, Aggarwal R, Mikolaitis RA, Niewold TB, Chubinskaya S, Block JA, Scanzello C, Sequeira W.
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [Abstract] [Full Text] [Related]

  • 4. Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus.
    Kaneko Y, Sato H, Wakamatsu A, Kobayashi D, Sato K, Kurosawa Y, Hasegawa E, Nakatsue T, Kuroda T, Narita I.
    Rheumatology (Oxford); 2024 May 02; 63(5):1411-1421. PubMed ID: 37572300
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan 02; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 6. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May 02; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 7. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.
    Ann Rheum Dis; 2009 Mar 02; 68(3):412-5. PubMed ID: 18930995
    [Abstract] [Full Text] [Related]

  • 8. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S, Lu R, Ritterhouse LL, Munroe ME, Maecker HT, Fathman CG, Utz PJ, Merrill JT, Guthridge JM, James JA.
    Arthritis Rheumatol; 2016 Oct 02; 68(10):2492-502. PubMed ID: 27059145
    [Abstract] [Full Text] [Related]

  • 9. [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.].
    Aleksandrova EN, Verizhnikova ZG, Novikov AA, Panafidina TA, Popkova TV, Lukina GV.
    Klin Lab Diagn; 2018 Oct 02; 63(7):434-438. PubMed ID: 30720960
    [Abstract] [Full Text] [Related]

  • 10. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R, Panda AK, Das BK.
    Lupus; 2015 Jan 02; 24(1):82-9. PubMed ID: 25253568
    [Abstract] [Full Text] [Related]

  • 11. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?
    Capper ER, Maskill JK, Gordon C, Blakemore AI.
    Clin Exp Immunol; 2004 Nov 02; 138(2):348-56. PubMed ID: 15498048
    [Abstract] [Full Text] [Related]

  • 12. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov 02; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Nov 02; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.
    J Rheumatol; 2006 Apr 02; 33(4):695-7. PubMed ID: 16583471
    [Abstract] [Full Text] [Related]

  • 15. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ, Zumaquero E, Rosal-Vela A, Khoo KM, Cerezo-Wallis D, García-Rodríguez S, Carrascal M, Abian J, Graeff R, Callejas-Rubio JL, Ortego-Centeno N, Malavasi F, Zubiaur M, Sancho J.
    Cytokine; 2013 May 02; 62(2):232-43. PubMed ID: 23538292
    [Abstract] [Full Text] [Related]

  • 16. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 May 02; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 17. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
    Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S.
    Lupus; 2012 Sep 02; 21(10):1098-104. PubMed ID: 22577117
    [Abstract] [Full Text] [Related]

  • 18. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun 02; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
    Atta AM, Santiago MB, Guerra FG, Pereira MM, Sousa Atta ML.
    Int Arch Allergy Immunol; 2010 Jun 02; 152(4):401-6. PubMed ID: 20197682
    [Abstract] [Full Text] [Related]

  • 20. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.
    Semin Arthritis Rheum; 2012 Jun 02; 41(6):840-8. PubMed ID: 22177108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.